d'Enfert, ChristopheKaune, Ann-KristinRey Alaban, LeovigildoChakraborty, SayoniCole, NathanielDelavy, MargotKosmala, DariaMarsaux, BenoîtFróisMartins, RicardoMorelli, MoranRosati, DilettaValentine, MarisaXie, ZixuanEmritloll, YoanWarn, Peter ABequet, FrédéricBougnoux, Marie-ElisabethBornes, StephanieGresnigt , Mark S.Hube, BernardJacobsen, lse D.Legrand, MelanieLeibundgut-Landmann, SaloméManichanh, ChaysavanhMunro, CarolNetea, Mihai G.Queiroz, KarlaRoget, KarineThomas, VincentThora, ClaudiaVan den Abbeele, PieterWalker, Alan WBrown, Alistair J.P.2021-09-252021-09-252021-05d'Enfert, C, Kaune, A-K, Rey Alaban, L, Chakraborty, S, Cole, N, Delavy, M, Kosmala, D, Marsaux, B, FróisMartins, R, Morelli, M, Rosati, D, Valentine, M, Xie, Z, Emritloll, Y, Warn, P A, Bequet, F, Bougnoux, M-E, Bornes, S, Gresnigt , M S, Hube, B, Jacobsen, L D, Legrand, M, Leibundgut-Landmann, S, Manichanh, C, Munro, C, Netea, M G, Queiroz, K, Roget, K, Thomas, V, Thora, C, Van den Abbeele, P, Walker, A W & Brown, A J P 2021, 'The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections : current knowledge and new perspectives', FEMS Microbiology Reviews, vol. 45, no. 3, fuaa060. https://doi.org/10.1093/femsre/fuaa0600168-6445ORCID: /0000-0001-5099-8495/work/94084612ORCID: /0000-0003-0761-1755/work/162729014https://hdl.handle.net/2164/17172ACKNOWLEDGEMENTS: We thank our friends and colleagues in the medical mycology, fungal immunology and microbiota fields for many thought-provoking discussions. FUNDING: We received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie action, Innovative Training Network: FunHoMic; grant N° 812969. CdE received funding from the French Government ‘Investissement d’Avenir’ program (Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases, ANR-10-LABX-62-IBEID), the Agence Nationale de la Recherche (ERA-Net Infect-ERA, FUNCOMPATH, ANR-14-IFEC-0004), the EU Horizon2020 consortium “Host-Directed Medicine in invasive FUNgal infections” - HDM-FUN (Grant Agreement 847507). SLL and CdE received funding from the Swiss National Science Foundation (Sinergia program, #CRSII5_173863). BIOASTER received funding from the French Government ‘Investissement d’Avenir’ program (Grant No. ANR-10-AIRT-03). MSG was supported by a Humboldt Research Fellowship for Postdoctoral Researchers by the Alexander von Humboldt-Foundation and the Deutsche Forschungsgemeinschaft (DFG) Emmy Noether Program (project no. 434385622 / GR 5617/1-1). BH was supported by the Deutsche Forschungsgemeinschaft (DFG) project Hu 532/20-1, project C1 within the Collaborative Research Centre (CRC)/Transregio 124 FungiNet and the Balance of the Microverse Cluster under Germany´s Excellence Strategy – EXC 2051 – Project-ID 390713860, the EU Horizon2020 consortium “Host-Directed Medicine in invasive FUNgal infections” - HDM-FUN (Grant Agreement 847507), the Leibniz Association Campus InfectoOptics SAS-2015-HKI-LWC and the Wellcome Trust (215599/Z/19/Z). IDJ was supported by the Deutsche orschungsgemeinschaft (DFG) project C5 within the Collaborative Research Centre (CRC)/Transregio 124 FungiNet and the Balance of the Microverse Cluster under Germany´s Excellence Strategy – EXC 2051 – Project-ID 390713860, the Leibniz Association Campus InfectoOptics SAS-2015-HKI-LWC and the Wellcome Trust (Grant 215599/Z/19/Z). CM received funding from the the Instituto de Salud Carlos III/FEDER. MGN was supported by an ERC Advanced Grant (#833247) and a Spinoza grant of the Netherlands Organization for Scientific Research. CAM was supported by EU Horizon2020 consortium “Host-Directed Medicine in invasive FUNgal infections” -HDM-FUN (Grant Agreement 847507) and the Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology (097377/Z/11/Z). AWW receives core funding support from the Scottish Government’s Rural and Environment Science and Analytical Services (RESAS). AJPB was supported by a programme grant from the UK Medical Research Council (MR/M026663/1) and by the Medical Research Council Centre for Medical Mycology at the University of Exeter (MR/N006364/1).555602047engCandidacandida infectionsantifungal immunitymicrobiotamycobiotafungus-host-microbiota interactionspatients variabilityfungal variabilitymicrobiota variabilityR MedicineWellcome Trust097377/Z/11/ZRural and Environmental Science and Analytical Services (RESAS)Medical Research Council (MRC)MR/M026663/1MR/N006364/1OtherEuropean Research Council#833247Supplementary DataRJournal item10.1093/femsre/fuaa060453